CYTO News and Press, Altamira Therapeutics Ltd. From 01/11/24

2024-01-11 08:33:48 ET Moolec Science  ( MLEC ) +46% . Transphorm  ( TGAN ) +30% to buy Transphorm to expand power portfolio with GaN technology. Spectaire Holdings  ( SPEC ) +28% Launches into European Trucking Market with Signed Distribut...

2024-01-08 17:09:26 ET More on Altamira Therapeutics Altamira shares sink over 40% on corporate, stock split updates Altamira stock rallies 130% in wake of Nasdaq update, unit sale For further details see: Altamira Therapeutics files to sell 162.5K shares

HAMILTON, BERMUDA , Jan. 08, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics to Present at 3 rd Annual mRNA-Based Therapeutics Summit Altamira’s two flagship programs, AM-401 and AM-411, designed for KRAS-driven cancer and rheumatoid arthritis, serve to demonstrate the t...

2023-12-29 08:53:57 ET More on Altamira Therapeutics Altamira shares sink over 40% on corporate, stock split updates Altamira stock rallies 130% in wake of Nasdaq update, unit sale For further details see: Altamira Therapeutics stock rises after it regains compli...

HAMILTON, BERMUDA, Dec. 29, 2023 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA, Dec. 29, 2023 -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, announced that it received a noti...

2023-12-14 05:51:41 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Altamira Therapeutics (NASDAQ: CYTO ) just reported results for the first half of 2023. Altamira Therapeutics reported earnings per share of -$28.20. The company repor...

2023-12-13 14:01:03 ET Altamira Therapeutics Ltd. (CYTO) Special Call December 11, 2023, 08:30 AM ET Company Participants Thomas Meyer - Founder, Chairman and CEO Conference Call Participants Presentation Operator Good morning, and welcome to ...

2023-12-11 10:25:29 ET More on Altamira Therapeutics Altamira Therapeutics Ltd. (CYTO) Q2 2023 Earnings Call Transcript Altamira stock rallies 130% in wake of Nasdaq update, unit sale Altamira stock surges after deal to sell 51% stake in Medica Financial info...

HAMILTON, BERMUDA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Company hosts Investor and Business Update call on December 11 at 8:30 a.m. ET Partial spin-off of Bentrio® business first step in transition to become ‘pure play’ RNA delivery company Transition ...

HAMILTON, BERMUDA , Dec. 05, 2023 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA--December 5, 2023--Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, announced today that it will host an Inves...